{"title":"在日本进行的一项多中心回顾性调查显示,术前自体献血的不良事件及其在产科患者中的应用","authors":"Akihiko Yokohama , Hiroshi Fujita , Kazuhiro Nagai , Shin-ichiro Fujiwara , Kazuki Tanimoto , Takashi Ushiki , Tomoko Henzan , Yoshihiro Hatta , Ryu Yanagisawa , Kazuaki Watanabe , Jun Murakami , Yuichi Hasegawa , Kazuhiko Ikeda , Keizo Fujino , Mayumi Matsumoto , Asashi Tanaka , Shigeyoshi Makino , Shuichi Kino , Akihiro Takeshita , Kazuo Muroi","doi":"10.1016/j.transci.2025.104131","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Evaluating the safety of preoperative autologous blood donation (PAD) and its transfusion is important, especially for young pregnant donors in an era of extremely low incidence of viral transmission.</div></div><div><h3>Materials and Methods</h3><div>Questionnaires were sent to hospitals, and safety information from donation to transfusion was collected and analyzed.</div></div><div><h3>Results</h3><div>Among 2378 obstetrical donors who underwent PAD, 1664 received autologous blood only (autologous group), 146 received allogeneic blood in addition to autologous blood (allogeneic group), and 568 received no transfusion (no transfusion group). Two hundred one of the 2378 patients (8.5 %) experienced adverse events (AEs) during PAD and its transfusion, although most AEs were mild. Even in the no-transfusion group, 8.1 % of patients experienced some AEs. The vasovagal reaction (VVR) rate was 2.6 % (n = 63). Other AE associated with donation developed in 114 patients (4.8 %), and they were the main components of all AEs; 32.5 % of them were unique to obstetric patients. Obstetrical donors with PAD may have disadvantages compared to donors with PAD in other settings. Transfusion reactions (TRs) occurred in 29 (1.2 %) patients. Surprisingly, the number of patients with TRs per unit did not differ significantly between the autologous and allogeneic groups.</div></div><div><h3>Conclusion</h3><div>Considering that most AEs occurred due to donation, PAD in obstetric patients was not beneficial. Moreover, similar TRs rates between the autologous and allogeneic groups did not indicate the priority of autologous blood. PAD should be performed by using a well-established transfusion management system.</div></div>","PeriodicalId":49422,"journal":{"name":"Transfusion and Apheresis Science","volume":"64 3","pages":"Article 104131"},"PeriodicalIF":1.2000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adverse events during preoperative autologous blood donation and its usage in obstetrical patients: A multicenter, retrospective survey in Japan\",\"authors\":\"Akihiko Yokohama , Hiroshi Fujita , Kazuhiro Nagai , Shin-ichiro Fujiwara , Kazuki Tanimoto , Takashi Ushiki , Tomoko Henzan , Yoshihiro Hatta , Ryu Yanagisawa , Kazuaki Watanabe , Jun Murakami , Yuichi Hasegawa , Kazuhiko Ikeda , Keizo Fujino , Mayumi Matsumoto , Asashi Tanaka , Shigeyoshi Makino , Shuichi Kino , Akihiro Takeshita , Kazuo Muroi\",\"doi\":\"10.1016/j.transci.2025.104131\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Evaluating the safety of preoperative autologous blood donation (PAD) and its transfusion is important, especially for young pregnant donors in an era of extremely low incidence of viral transmission.</div></div><div><h3>Materials and Methods</h3><div>Questionnaires were sent to hospitals, and safety information from donation to transfusion was collected and analyzed.</div></div><div><h3>Results</h3><div>Among 2378 obstetrical donors who underwent PAD, 1664 received autologous blood only (autologous group), 146 received allogeneic blood in addition to autologous blood (allogeneic group), and 568 received no transfusion (no transfusion group). Two hundred one of the 2378 patients (8.5 %) experienced adverse events (AEs) during PAD and its transfusion, although most AEs were mild. Even in the no-transfusion group, 8.1 % of patients experienced some AEs. The vasovagal reaction (VVR) rate was 2.6 % (n = 63). Other AE associated with donation developed in 114 patients (4.8 %), and they were the main components of all AEs; 32.5 % of them were unique to obstetric patients. Obstetrical donors with PAD may have disadvantages compared to donors with PAD in other settings. Transfusion reactions (TRs) occurred in 29 (1.2 %) patients. Surprisingly, the number of patients with TRs per unit did not differ significantly between the autologous and allogeneic groups.</div></div><div><h3>Conclusion</h3><div>Considering that most AEs occurred due to donation, PAD in obstetric patients was not beneficial. Moreover, similar TRs rates between the autologous and allogeneic groups did not indicate the priority of autologous blood. PAD should be performed by using a well-established transfusion management system.</div></div>\",\"PeriodicalId\":49422,\"journal\":{\"name\":\"Transfusion and Apheresis Science\",\"volume\":\"64 3\",\"pages\":\"Article 104131\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transfusion and Apheresis Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1473050225000655\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion and Apheresis Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1473050225000655","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Adverse events during preoperative autologous blood donation and its usage in obstetrical patients: A multicenter, retrospective survey in Japan
Background
Evaluating the safety of preoperative autologous blood donation (PAD) and its transfusion is important, especially for young pregnant donors in an era of extremely low incidence of viral transmission.
Materials and Methods
Questionnaires were sent to hospitals, and safety information from donation to transfusion was collected and analyzed.
Results
Among 2378 obstetrical donors who underwent PAD, 1664 received autologous blood only (autologous group), 146 received allogeneic blood in addition to autologous blood (allogeneic group), and 568 received no transfusion (no transfusion group). Two hundred one of the 2378 patients (8.5 %) experienced adverse events (AEs) during PAD and its transfusion, although most AEs were mild. Even in the no-transfusion group, 8.1 % of patients experienced some AEs. The vasovagal reaction (VVR) rate was 2.6 % (n = 63). Other AE associated with donation developed in 114 patients (4.8 %), and they were the main components of all AEs; 32.5 % of them were unique to obstetric patients. Obstetrical donors with PAD may have disadvantages compared to donors with PAD in other settings. Transfusion reactions (TRs) occurred in 29 (1.2 %) patients. Surprisingly, the number of patients with TRs per unit did not differ significantly between the autologous and allogeneic groups.
Conclusion
Considering that most AEs occurred due to donation, PAD in obstetric patients was not beneficial. Moreover, similar TRs rates between the autologous and allogeneic groups did not indicate the priority of autologous blood. PAD should be performed by using a well-established transfusion management system.
期刊介绍:
Transfusion and Apheresis Science brings comprehensive and up-to-date information to physicians and health care professionals involved in the rapidly changing fields of transfusion medicine, hemostasis and apheresis. The journal presents original articles relating to scientific and clinical studies in the areas of immunohematology, transfusion practice, bleeding and thrombotic disorders and both therapeutic and donor apheresis including hematopoietic stem cells. Topics covered include the collection and processing of blood, compatibility testing and guidelines for the use of blood products, as well as screening for and transmission of blood-borne diseases. All areas of apheresis - therapeutic and collection - are also addressed. We would like to specifically encourage allied health professionals in this area to submit manuscripts that relate to improved patient and donor care, technical aspects and educational issues.
Transfusion and Apheresis Science features a "Theme" section which includes, in each issue, a group of papers designed to review a specific topic of current importance in transfusion and hemostasis for the discussion of topical issues specific to apheresis and focuses on the operators'' viewpoint. Another section is "What''s Happening" which provides informal reporting of activities in the field. In addition, brief case reports and Letters to the Editor, as well as reviews of meetings and events of general interest, and a listing of recent patents make the journal a complete source of information for practitioners of transfusion, hemostasis and apheresis science. Immediate dissemination of important information is ensured by the commitment of Transfusion and Apheresis Science to rapid publication of both symposia and submitted papers.